Sensus Healthcare, Inc.
SRTS
$4.19
$0.081.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.88M | 7.32M | 8.34M | 13.07M | 8.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.88M | 7.32M | 8.34M | 13.07M | 8.84M |
| Cost of Revenue | 4.17M | 4.41M | 3.99M | 5.96M | 3.60M |
| Gross Profit | 2.71M | 2.90M | 4.35M | 7.11M | 5.24M |
| SG&A Expenses | 3.46M | 3.38M | 4.39M | 3.82M | 2.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.45M | 9.26M | 10.99M | 11.34M | 7.34M |
| Operating Income | -2.57M | -1.94M | -2.65M | 1.73M | 1.50M |
| Income Before Tax | -2.41M | -1.76M | -2.46M | 1.96M | 1.77M |
| Income Tax Expenses | -1.47M | -723.00K | 110.00K | 410.00K | 559.00K |
| Earnings from Continuing Operations | -943.00K | -1.04M | -2.57M | 1.55M | 1.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -943.00K | -1.04M | -2.57M | 1.55M | 1.22M |
| EBIT | -2.57M | -1.94M | -2.65M | 1.73M | 1.50M |
| EBITDA | -2.47M | -1.84M | -2.56M | 1.81M | 1.55M |
| EPS Basic | -0.06 | -0.06 | -0.16 | 0.09 | 0.07 |
| Normalized Basic EPS | -0.09 | -0.07 | -0.09 | 0.07 | 0.07 |
| EPS Diluted | -0.06 | -0.06 | -0.16 | 0.09 | 0.07 |
| Normalized Diluted EPS | -0.09 | -0.07 | -0.09 | 0.07 | 0.07 |
| Average Basic Shares Outstanding | 16.32M | 16.32M | 16.34M | 16.33M | 16.32M |
| Average Diluted Shares Outstanding | 16.32M | 16.32M | 16.34M | 16.44M | 16.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |